Gordon Ralph Corey, MD

Professor of Medicine
Gary Hock Professor in Global Health, in the School of Medicine
Vice-Chair for Education and Global Health in the Department of Medicine
Research Professor of Global Health
Professor of Pathology
Member in the Duke Clinical Research Institute
Campus mail 310 Trent Drive Room 235 Trent, Box 90519, Durham, NC 27708
Phone (919) 668-7174
Email address corey001@mc.duke.edu

My research is based at the Duke Clinical Research Institute, a large academic clinical research organization designed to conduct clinical trials from small local studies to worldwide trials. The focus of my research is bacterial infections: complicated skin and skin structure infections; postoperative wound infections; hospital-acquired and ventilator-associated pneumonia; bacteremia; and endocarditis. Many of these trials are conducted in concert with the pharmaceutical industry in order to register new antibiotics. In addition, as director of infectious diseases at the DCRI I oversee the work of the mycology group, and tuberculosis trials. This work also includes work supported by NIH grants including sepsis trials, the Staph Aureus and Staph Epi Bacteremia Groups, and the International Collaboration of Endocarditis. The team of investigators with whom I work is highly experienced, amazingly productive and wonderfully collegial.

As a result of my longstanding interest in tropical medicine and the generosity of my patients as well as the Hubert Family we have been able to establish the Hubert-Yeargan Center for Global Health. As a result we have developed a medical center-wide fellowship in Global Health. I am presently the Director of the Center and the Gary Hock Distinguished Professor of Global Health.

Education and Training

  • Fellowship, Infectious Diseases, Duke University School of Medicine, 1978 - 1980
  • Chief Resident, General Internal Medicine, Duke University School of Medicine, 1977 - 1978
  • Residency, General Internal Medicine, Duke University School of Medicine, 1975 - 1977
  • Internship, General Internal Medicine, Duke University School of Medicine, 1974 - 1975
  • M.D., Baylor University, 1973

Publications

Corey, GR, and Stryjewski, ME. "New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the good." Clin Infect Dis 52 Suppl 7 (June 2011): S469-S476.

PMID
21546623
Full Text

Bloomfield, GS, Kimaiyo, S, Carter, EJ, Binanay, C, Corey, GR, Einterz, RM, Tierney, WM, and Velazquez, EJ. "Chronic noncommunicable cardiovascular and pulmonary disease in sub-Saharan Africa: an academic model for countering the epidemic." Am Heart J 161, no. 5 (May 2011): 842-847. (Review)

PMID
21570512
Full Text

Chow, S-C, and Corey, R. "Benefits, challenges and obstacles of adaptive clinical trial designs." Orphanet Journal of Rare Diseases 6, no. 1 (2011).

PMID
22129361
Full Text

Thornhill, MH, Dayer, MJ, Forde, JM, Corey, GR, Chu, VH, Couper, DJ, and Lockhart, PB. "Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: Before and after study." BMJ 342, no. 7807 (2011).

PMID
21540258
Full Text

Thornhill, MH, Dayer, MJ, Forde, JM, Corey, GR, Chu, VH, Couper, DJ, and Lockhart, PB. "Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study." BMJ (Clinical research ed.) 342 (2011): d2392-.

Full Text

Rubinstein, E, Corey, GR, Stryjewski, ME, and Kanafani, ZA. "Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia." Expert Opinion on Pharmacotherapy 12, no. 17 (2011): 2737-2750.

PMID
22077833
Full Text

Corey, GR, and Stryjewski, ME. "Reply to Spellberg." Clinical Infectious Diseases 53, no. 12 (2011): 1309-1310.

Full Text

Corey, GR. "Staphylococcus aureus bacteremia and endocarditis:: The Role of diagnostic evaluation." Infectious Diseases in Clinical Practice 19, no. 5 (2011): 307-312.

Full Text

Rubinstein, E, Corey, GR, Stryjewski, ME, and Barriere, SL. "Reply to Tarchini." Clinical Infectious Diseases 52, no. 11 (2011): 1391-1392.

Full Text

Craft, JC, Moriarty, SR, Clark, K, Scott, D, Degenhardt, TP, Still, JG, Corey, GR, Das, A, and Fernandes, P. "A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections." Clinical Infectious Diseases 52, no. SUPPL. 7 (2011): S520-S526.

PMID
21546629
Full Text

Pages